Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity
Himmelstein, D.U.; Woolhandler, S.J.; Adler, R.D.
American Journal of Gastroenterology 79(9): 718-720
1984
ISSN/ISBN: 0002-9270 PMID: 6475903 Document Number: 239625
Two alcoholic patients with acetaminophen hepatotoxicity are described. Both patients had very high SGOT levels and SGOT/SGPT ratios. It is suggested that a high SGOT/SGPT ratio is not specific for alcoholic hepatitis. Extreme elevations of this ratio, especially in association with SGOT levels greater than five times normal, should suggest nonalcoholic causes of hepatocellular necrosis in alcoholic patients.
Document emailed within 1 workday
Related Documents
Chomchai, S.; Lawattanatrakul, N.; Chomchai, C. 2014: Acetaminophen Psi Nomogram: a sensitive and specific clinical tool to predict hepatotoxicity secondary to acute acetaminophen overdose Journal of the Medical Association of Thailand 97(2): 165-172Grgicević, D. 1983: The effect of long-term plasmapheresis on the composition of blood. III. Changes in the concentration of total, direct and indirect bilirubin, alkaline phosphatase, serum transaminases (SGOT, SGPT). total lipids, triglycerides and cholesterol Bilten Za Hematologiju i Transfuziju 11(2-3): 39-50
Seifert, C.F.; Lucas, D.S.; Vondracek, T.G.; Kastens, D.J.; McCarty, D.L.; Bui, B. 1993: Patterns of acetaminophen use in alcoholic patients PharmacoTherapy 13(4): 391-395
Gale, G.R.; Smith, A.B. 1988: Interaction of caffeine with acetaminophen in mice: schedule dependency of the antagonism by caffeine of acetaminophen hepatotoxicity and the effects of caffeine metabolites, allopurinol, and diethyl ether Research Communications in Chemical Pathology and Pharmacology 59(3): 305-320
Ueno, K.; Yamaura, K.; Nakamura, T.; Satoh, T.; Yano, S. 2000: Acetaminophen-induced immunosuppression associated with hepatotoxicity in mice Research Communications in Molecular Pathology and Pharmacology 108(3-4): 237-251
Salas Coll, C.A.; Torrealba de Ron, A.T.; Morales de Martínez, A.; Fernández, L.; Mago, A. 1995: Effects of cholestasis on hepatotoxicity of acetaminophen in rats G.E.N 49(1): 42-49
Seirafi, M.; Iten, A.; Hadengue, A. 2007: Acetaminophen: hepatotoxicity at therapeutic doses and risk factors Revue Medicale Suisse 3(129): 2345-2349
Kalhorn, T.F.; Lee, C.A.; Slattery, J.T.; Nelson, S.D. 1990: Effect of methylxanthines on acetaminophen hepatotoxicity in various induction states Journal of Pharmacology and Experimental Therapeutics 252(1): 112-116
Burk, R.F.; Hill, K.E.; Hunt, R.W.; Martin, A.E. 1990: Isoniazid potentiation of acetaminophen hepatotoxicity in the rat and 4-methylpyrazole inhibition of it Research Communications in Chemical Pathology and Pharmacology 69(1): 115-118
Karczmarek-Borowska, B.; Drzymała, M.łg.; Golon, K. 2014: Hepatotoxicity of acetaminophen in a patient treated with capecitabine due to breast cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(215): 348-351
Woo, I.; Tobler, K.; Khafagy, A.; Christianson, M.S.; Yates, M.; Garcia, J. 2015: Predictive Value of Elevated LH/FSH Ratio for Ovulation Induction in Patients with Polycystic Ovary Syndrome Journal of Reproductive Medicine 60(11-12): 495-500
Liu, J.; Liu, Y.; Madhu, C.; Klaassen, C.D. 1993: Protective effects of oleanolic acid on acetaminophen-induced hepatotoxicity in mice Journal of Pharmacology and Experimental Therapeutics 266(3): 1607-1613
Kostrubsky, V.E.; Szakacs, J.G.; Jeffery, E.H.; Woods, S.G.; Bement, W.J.; Wrighton, S.A.; Sinclair, P.R.; Sinclair, J.F. 1997: Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A Annals of Clinical and Laboratory Science 27(1): 57-62
Brady, J.T.; Birge, R.B.; Khairallah, E.A.; Cohen, S.D. 1991: Post-treatment protection with piperonyl butoxide against acetaminophen hepatotoxicity is associated with changes in selective but not total covalent binding Advances in Experimental Medicine and Biology 283: 689-692
Burkart, J.M.; Bleyer, A.J.; Jordan, J.R.; Zeigler, N.C. 1996: An elevated ratio of measured to predicted creatinine production in CAPD patients is not a sensitive predictor of noncompliance with the dialysis prescription Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 16(2): 142-146
Casacchia, M.; Meco, G.; Carchedi, F.; Paris, L.; Avoli, M.; Cerbo, R. 1978: Usefulness of gamma-glutamyltransferase in alcoholic hepatotoxicity Bollettino della Societa Italiana di Biologia Sperimentale 53(24): 2493-2496
Villeneuve, J.P.; Raymond, G.; Bruneau, J.; Colpron, L.; Pomier-Layrargues, G. 1983: Pharmacokinetics and metabolism of acetaminophen in normal, alcoholic and cirrhotic subjects Gastroenterologie Clinique et Biologique 7(11): 898-902
Worriax, J.D.; Yates, J.E.; Flake, D.; Saseen, J.J. 2007: Clinical inquiries. Alcoholic liver disease: is acetaminophen safe? Journal of Family Practice 56(8): 673-674
Skoglund, L.A.; Skjelbred, P.; Fyllingen, G. 1991: Analgesic efficacy of acetaminophen 1000 mg, acetaminophen 2000 mg, and the combination of acetaminophen 1000 mg and codeine phosphate 60 mg versus placebo in acute postoperative pain PharmacoTherapy 11(5): 364-369
Sheron, N.; Bird, G.; Goka, J.; Alexander, G.; Williams, R. 1991: Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis Clinical and Experimental Immunology 84(3): 449-453